Not to be Sneezed At
One of the stand-out technologies discussed by London-based immuno-oncology start-up Epsilogen was in antibody therapeutics…..
See the article in full here: https://www.genengnews.com/gen-exclusives/biotrinity-conference-focuses-on-nextgen-healthcare/77901102
